hydromorphone has been researched along with Nerve Pain in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuda, Y; Niki, K; Okamoto, Y; Omae, T; Takagi, T; Takemura, M; Ueda, M | 1 |
| Falke, D; Gálvez, R; Hans, G; Schäfer, M; Steigerwald, I | 1 |
| Casali, M; Dauri, M; Lazzari, M; Sabato, AF; Sabato, E; Tufaro, G | 1 |
| Aldington, D; Cole, P; Cooper, TE; Derry, S; Gaskell, H; Knaggs, R; Moore, RA; Stannard, C; Wiffen, PJ | 1 |
| Jacobs, A; Moulin, DE; Richarz, U; Thipphawong, J; Wallace, M | 1 |
| Brown, C; Heath, TD; Krugner-Higby, LA; Smith, LJ; Valenzuela, JR | 1 |
| Buechler, NL; Eisenach, JC; Kim, SA; Martin, TJ; Porreca, F | 1 |
| Saulino, M | 1 |
2 review(s) available for hydromorphone and Nerve Pain
| Article | Year |
|---|---|
Hydromorphone for neuropathic pain in adults.
Topics: Adult; Analgesics, Opioid; Chronic Pain; Humans; Hydromorphone; Neuralgia; Randomized Controlled Trials as Topic | 2016 |
Efficacy of the sustained-release hydromorphone in neuropathic pain management: pooled analysis of three open-label studies.
Topics: Analgesics, Opioid; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Middle Aged; Neuralgia; Pain Measurement; Palliative Care; Treatment Outcome | 2010 |
1 trial(s) available for hydromorphone and Nerve Pain
| Article | Year |
|---|---|
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Delayed-Action Preparations; Female; Fentanyl; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Morphine; Neuralgia; Oxycodone; Pain Measurement; Phenols; Severity of Illness Index; Tapentadol | 2013 |
5 other study(ies) available for hydromorphone and Nerve Pain
| Article | Year |
|---|---|
Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Hydromorphone; Japan; Male; Methadone; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Retrospective Studies; Tapentadol | 2021 |
Long-term efficacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain.
Topics: Adult; Aged; Aged, 80 and over; Chronic Pain; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Female; gamma-Aminobutyric Acid; Humans; Hydromorphone; Male; Middle Aged; Neuralgia; Pain Management; Pregabalin; Young Adult | 2014 |
A single dose of liposome-encapsulated hydromorphone provides extended analgesia in a rat model of neuropathic pain.
Topics: Analgesics, Opioid; Animals; Delayed-Action Preparations; Disease Models, Animal; Hydromorphone; Hyperalgesia; Liposomes; Male; Neuralgia; Rats; Rats, Sprague-Dawley; Time Factors | 2006 |
Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics.
Topics: Adenosine; Analgesics, Opioid; Animals; Clonidine; Dose-Response Relationship, Drug; Fentanyl; Heroin; Hydromorphone; Infusions, Intravenous; Injections, Spinal; Male; Methadone; Morphine; Neuralgia; Pain; Rats; Rats, Inbred F344; Self Administration | 2007 |
Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report.
Topics: Adult; Analgesics; Drug Therapy, Combination; Female; Humans; Hydromorphone; Injections, Spinal; Neuralgia; omega-Conotoxins; Pain Measurement; Spinal Cord Injuries | 2007 |